Pancreatic Cancer Drug Shows Promise for Lung Cancer Treatment

New clinical trial data suggests that the targeted cancer drug Daraxonrasib, originally developed for pancreatic cancer, may also offer therapeutic benefits for certain lung cancer patients.

4 Sept, 19:43 — 4 Sept, 19:43

Post Share

Sources

Showing 1 of 1 sources

forbes15h ago

Breakthrough Pancreatic Cancer Drug Might Also Work In Lung Cancer

New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung cancer.

By Victoria Forster, Contributor

Read full article →

Pancreatic Cancer Drug Shows Promise for Lung Cancer Treatment

Sources

Breakthrough Pancreatic Cancer Drug Might Also Work In Lung Cancer

Related Stories

Bangladesh Measles Epidemic Nears 1,000 Child Fatalities

West Nile Virus Cases Surpass 1,000 Across Europe

Haze Drives Unhealthy Air Quality Across Southeast Asian Cities

Experimental Heart Drug Fails Key Trial Milestone